Healing Peptide
Also known as: repair peptide · tissue repair peptide
'Healing peptide' is an informal label for peptides promoted for tissue repair, such as BPC-157 and TB-500; their evidence comes mostly from animal studies.
There is no pharmacological or regulatory class called "healing peptides." The term groups compounds promoted for recovery from tendon, ligament, muscle, and other injuries, most often BPC-157, thymosin beta-4 and its fragment TB-500, and GHK-Cu. BPC-157 is not FDA-approved, and a 2026 sports-medicine review discussed these peptides among compounds marketed directly to patients, noting that many unapproved peptides show favorable tissue-repair outcomes in animal models while rigorous human safety data are scarce.
The proposed mechanisms come mainly from lab and animal work. For BPC-157, a 2025 systematic review reported that studies suggest it increases growth hormone receptor expression and pathways involved in cell growth and new blood vessel formation (angiogenesis), while reducing inflammatory cytokines. In animal models it improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bone injuries. The same review reported that BPC-157 is metabolized in the liver with a half-life of less than 30 minutes.
Why it matters
The gap between animal and human evidence is large. The BPC-157 systematic review searched the literature through June 2024 and included 36 studies: 35 preclinical and 1 clinical. That single human study was retrospective: 7 of 12 people with chronic knee pain reported relief lasting more than 6 months after an injection into the knee joint. The review found no clinical safety data.
Product quality adds its own risk. The review's authors noted possible adverse effects from unregulated manufacturing and contamination, and that BPC-157 is banned in professional sports. The 2026 review warned of potential for serious harm and discussed the placebo effect, amplified by social media, as a factor in how people judge these peptides. Many injuries improve with time and rehabilitation, which makes it hard to credit any single compound for a recovery without a comparison group.
How to weigh the evidence
- Separate cell and animal results from human results; most findings for this group are preclinical.
- For any human study, check whether it had a control group, how many people were in it, and how outcomes were measured.
- Check whether the product's identity and purity have been independently tested, since these compounds are not made under drug-approval oversight.
- Note how the compound was given in any human study; a single injection into a knee joint tells you little about other routes or other injuries.
- If you compete in a tested sport, check your organization's prohibited list before using anything.
Common mistakes
- Citing animal tendon or muscle results as proof the compound works in people.
- Reading "7 of 12 patients reported relief" from an uncontrolled retrospective study as evidence of efficacy.
- Assuming "naturally occurring" or "gastric peptide" means low risk.
- Ignoring how strong placebo effects can be for pain and recovery outcomes.
- Assuming a vial labeled BPC-157 contains only BPC-157 without independent testing.
Sources
- Systematic reviewEmerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J, 2025. PMID 40756949.
- ReviewSafety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med, 2026. PMID 41966639.
Page updated . How we grade evidence: methodology.
Related Terms
Angiogenesis
Angiogenesis is the growth of new blood vessels from existing ones, a normal part of development and wound repair that tumors can also exploit.
Cytokine Modulation
Cytokine modulation is changing the levels or effects of cytokines, the small signaling proteins that start, steer and end inflammation.
Stack
A stack is two or more compounds used during the same period, usually chosen because they are thought to act through different mechanisms on the same goal.
Peptide
A peptide is a short chain of amino acids joined by peptide bonds. US regulators treat chains of 40 or fewer amino acids as peptides.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial